Position in ONC
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$105,147,660
+$1,311,803 QoQ
Shares Held
368,978
+5.5% QoQ
Ownership
0.326%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#14
of 282 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in ONC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Baird Financial Group, Inc. holds $221,188,371 across 29 Biotechnology names. ONC ranks #1 (47.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ONC |
BeOne Medicines Ltd.
This page
|
368,978 | $105,147,660 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
52,845 | $32,950,970 | |
| 3 | INCY |
Incyte Corp
|
224,855 | $25,489,561 | |
| 4 | EXEL |
Exelixis, Inc.
|
437,138 | $23,784,676 | |
| 5 | INVA |
Innoviva, Inc.
|
274,391 | $6,231,419 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
38,672 | $2,880,290 | |
| 7 | ASND |
Ascendis Pharma A/S
|
10,735 | $2,863,239 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
8,550 | $2,702,569 |
All Filings in ONC
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $105,147,660 | 368,978 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $103,835,857 | 349,651 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $92,461,230 | 304,339 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $116,833,525 | 342,922 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $82,894,934 | 342,442 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $74,682,359 | 274,396 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $54,593,257 | 295,562 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $64,459,964 | 287,114 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $37,395,233 | 262,110 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $39,233,090 | 250,867 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $29,747,315 | 164,933 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $23,464,400 | 130,452 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $20,538,019 | 115,188 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $22,890,579 | 106,206 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $22,697,808 | 103,200 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,964,116 | 103,576 | Shares | Defined | 2022-11-15 | |
| 2022-06-30 | $15,824,397 | 97,772 | Shares | Defined | 2022-08-08 | |
| 2022-03-31 | $17,653,337 | 93,602 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $22,930,160 | 84,635 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $30,489,096 | 83,992 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $27,410,242 | 79,869 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $25,550,464 | 73,404 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $21,186,171 | 81,993 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $22,901,737 | 79,953 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $14,623,042 | 77,617 | Shares | Defined | 2020-10-22 | |
| 2020-03-31 | $9,188,314 | 74,635 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||